Costantino Ambrosio
Direktor/Vorstandsmitglied bei Vicuron Pharmaceuticals LLC
Profil
Costantino Ambrosio has been Chief Manufacturing Officer and a Director of Vicuron Pharmaceuticals, Inc. since March 2003.
Prior to joining Vicuron Pharmaceuticals, he was Executive Vice President of Manufacturing for Biosearch Italia SpA.
Mr. Ambrosio was General Manufacturing Manager of Dow Iberica from 1996 to 1998 and Dow Italia from 1991 to 1996 and a Principal of Merrell Dow USA from 1988 to 1991.
Previously, he held manufacturing positions at Dow Chemical's Gruppo Lepitit Brindisi from 1971 to 1988.
Prior to his current position, Mr. Ambrosio was an Executive Vice President of Vicuron Pharmaceuticals.
Aktive Positionen von Costantino Ambrosio
| Unternehmen | Position | Beginn |
|---|---|---|
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Costantino Ambrosio
| Unternehmen | Position | Ende |
|---|---|---|
| Merrell Dow USA | Corporate Officer/Principal | 01.01.1991 |
| Biosearch Italia SpA | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
| Biosearch Italia SpA | Health Technology |
| Merrell Dow USA |
